CIK: 1342826 - Address: C/O Maxcyte, Inc., 9713 Key West Avenue, Suite 400, Rockville, MD 20850
42 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
P%ret2111461329838737
P%wins91708080807078
S%ret111-30-532-64-82-24
S%wins100100100010010083

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
11/5/24 16:25
11/1/24
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiErck Stanley CMDDM.d20.040004822269D
11/5/24 16:25
11/1/24
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiErck Stanley CMDDS.d-1773.720-48-15269D
10/2/24 17:03
10/1/24
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiErck Stanley CMDDM.dm20.040004822269D
10/2/24 17:03
10/1/24
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiErck Stanley CMDDS.dm-1793.750-48-15269D
9/5/24 17:10
9/3/24
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiErck Stanley CMDDM.dm20.040004822269D
9/5/24 17:10
9/3/24
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiErck Stanley CMDDS.dm-1924.020-48-15269D
12/16/22 17:00
12/14/22
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOM.d00.00072436D
9/28/22 17:02
9/26/22
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOM.d00.00072632D
12/16/21 17:14
12/14/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOM.d00.00073427D
10/5/21 17:05
10/4/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOM.d1,17627.4504324D
10/5/21 17:05
10/4/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOS.d-7,544176.150-43-6424D
10/5/21 17:04
10/1/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOM.d1,33127.1704924D
10/5/21 17:04
10/1/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOS.d-8,580175.100-49-6724D
9/28/21 17:02
9/26/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOM.d00.00073824D
7/6/21 17:03
7/1/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOM.dm7,48071.12010520D
7/6/21 17:03
7/1/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOS.dm-22,549214.380-105-8420D
11/18/20 18:09
11/16/20
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOM.d1,94337.1405220D
11/18/20 18:09
11/16/20
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOS.d-4,74390.650-52-7220D
10/1/20 17:39
9/30/20
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOS.m-1,348110.230-12-3720D
9/30/20 21:27
9/28/20
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOM.d2985.9505033D
9/30/20 21:27
9/28/20
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOS.dm-3,201109.950-29-4733D
9/29/20 18:16
9/26/20
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOM.d00.00073625D
3/10/20 16:58
3/8/20
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOM.d00.00064220D
11/30/18 16:02
11/28/18
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CNCDM.d121.49082148D
5/15/18 11:13
5/14/18
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOP1651.65010044328D
11/13/17 08:13
11/9/17
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOP1131.13010078228D
5/11/17 10:29
5/11/17
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOP420.839645064128D-90-82-44-37-35111212
4/1/16 17:34
3/30/16
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOM.dm5121.283040078D14-38-20-4169-22-30-532-64-82
4/1/16 17:34
3/30/16
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOS.dm-2,2045.1930-425-8478D14-38-20-4169-22-30-532-64-82
2/1/16 17:30
1/31/16
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOCEO,PP94.383322103D-10-34-57-30-41-27-17-9-7-4-7444-73
8/4/15 16:43
7/31/15
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOCEO,PP72.283333101D3521845751220122-5-10-41-58-38
2/3/15 17:04
1/31/15
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOCEO,PP142.28336798D3314281373020513718760-36
8/4/14 15:11
7/31/14
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOCEO,PP152.28147892D9559-22-1-15-5-6-532143281184
3/25/14 14:08
3/25/14
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOCEO,PP.a434.2733101385D2159132-12-29-35-24-208101184124
3/25/14 12:02
3/25/14
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOCEO,PP434.2733101385D2159132-12-29-35-24-208101184124
2/4/14 09:19
1/31/14
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOP272.2932121975D251194997113-4-17-721020-18-1741
8/23/11 09:33
8/19/11
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOP161.26113New13D-74-40-43-48-37-29-7-95352291059
8/11/11 10:15
8/9/11
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOP.m621.2415017D-74-42-45-46-38-41-32-1461037261358
3/16/09 08:07
3/12/09
BCRXBiocryst Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CALDP491.22040New402-1430231690430
7/31/08 16:42
7/29/08
IOMIIomai CorpHealthDrugPharmaceutical PreparationsErck Stanley CMDDOP,CEOM.dm7305.28013825D
7/31/08 16:42
7/29/08
IOMIIomai CorpHealthDrugPharmaceutical PreparationsErck Stanley CMDDOP,CEOS.dm-9066.560-138-8525D
8/20/07 16:37
8/16/07
IOMIIomai CorpHealthDrugPharmaceutical PreparationsErck Stanley CMDDOP,CEOM.d230.9100025New25D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact